Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

William T Triplett

Showing results (1-10 of 20) with videos related to

Pageof 2
Sort By:
Frontiers in Human Neuroscience|July 31, 2013
Imaging white matter in human brainstemAnastasia A Ford, Luis Colon-Perez, William T Triplett, et al.
Muscle & Nerve|January 25, 2018
Leg muscle MRI in identical twin boys with duchenne muscular dystrophyRebecca J Willcocks, William T Triplett, Donovan J Lott, et al.
Journal of Pharmacokinetics and Pharmacodynamics|April 12, 2024
Five multivariate Duchenne muscular dystrophy progression models bridging six-minute walk distance and MRI relaxometry of leg musclesDeok Yong Yoon, Michael J Daniels, Rebecca J Willcocks, et al.
NMR in Biomedicine|October 10, 2012
T₂ mapping provides multiple approaches for the characterization of muscle involvement in neuromuscular diseases: a cross-sectional study of lower leg muscles in 5-15-year-old boys with Duchenne muscular dystrophyIshu Arpan, Sean C Forbes, Donovan J Lott, et al.
Journal of Neurology|July 28, 2019
Imaging respiratory muscle quality and function in Duchenne muscular dystrophyAlison M Barnard, Donovan J Lott, Abhinandan Batra, et al.
Chest|September 18, 2021
Characterizing Expiratory Respiratory Muscle Degeneration in Duchenne Muscular Dystrophy Using MRIAlison M Barnard, Donovan J Lott, Abhinandan Batra, et al.
Magnetic Resonance in Medicine|September 6, 2013
Chemical shift-based MRI to measure fat fractions in dystrophic skeletal muscleWilliam T Triplett, Celine Baligand, Sean C Forbes, et al.
CPT: Pharmacometrics & Systems Pharmacology|August 3, 2023
Multivariate modeling of magnetic resonance biomarkers and clinical outcome measures for Duchenne muscular dystrophy clinical trialsSarah Kim, Rebecca J Willcocks, Michael J Daniels, et al.
Annals of Clinical and Translational Neurology|November 7, 2023
Clinical importance of changes in magnetic resonance biomarkers for Duchenne muscular dystrophyRebecca J Willcocks, Alison M Barnard, Michael J Daniels, et al.
Neuromuscular Disorders : NMD|March 8, 2021
Disease-modifying effects of edasalonexent, an NF-κB inhibitor, in young boys with Duchenne muscular dystrophy: Results of the MoveDMD phase 2 and open label extension trialRichard S Finkel, Erika Finanger, Krista Vandenborne, et al.
Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
Frontiers in Human Neuroscience|July 31, 2013
Imaging white matter in human brainstemAnastasia A Ford, Luis Colon-Perez, William T Triplett, et al.
Muscle & Nerve|January 25, 2018
Leg muscle MRI in identical twin boys with duchenne muscular dystrophyRebecca J Willcocks, William T Triplett, Donovan J Lott, et al.
Journal of Pharmacokinetics and Pharmacodynamics|April 12, 2024
Five multivariate Duchenne muscular dystrophy progression models bridging six-minute walk distance and MRI relaxometry of leg musclesDeok Yong Yoon, Michael J Daniels, Rebecca J Willcocks, et al.
NMR in Biomedicine|October 10, 2012
T₂ mapping provides multiple approaches for the characterization of muscle involvement in neuromuscular diseases: a cross-sectional study of lower leg muscles in 5-15-year-old boys with Duchenne muscular dystrophyIshu Arpan, Sean C Forbes, Donovan J Lott, et al.
Journal of Neurology|July 28, 2019
Imaging respiratory muscle quality and function in Duchenne muscular dystrophyAlison M Barnard, Donovan J Lott, Abhinandan Batra, et al.
Chest|September 18, 2021
Characterizing Expiratory Respiratory Muscle Degeneration in Duchenne Muscular Dystrophy Using MRIAlison M Barnard, Donovan J Lott, Abhinandan Batra, et al.
Magnetic Resonance in Medicine|September 6, 2013
Chemical shift-based MRI to measure fat fractions in dystrophic skeletal muscleWilliam T Triplett, Celine Baligand, Sean C Forbes, et al.
CPT: Pharmacometrics & Systems Pharmacology|August 3, 2023
Multivariate modeling of magnetic resonance biomarkers and clinical outcome measures for Duchenne muscular dystrophy clinical trialsSarah Kim, Rebecca J Willcocks, Michael J Daniels, et al.
Annals of Clinical and Translational Neurology|November 7, 2023
Clinical importance of changes in magnetic resonance biomarkers for Duchenne muscular dystrophyRebecca J Willcocks, Alison M Barnard, Michael J Daniels, et al.
Neuromuscular Disorders : NMD|March 8, 2021
Disease-modifying effects of edasalonexent, an NF-κB inhibitor, in young boys with Duchenne muscular dystrophy: Results of the MoveDMD phase 2 and open label extension trialRichard S Finkel, Erika Finanger, Krista Vandenborne, et al.
Pageof 2